Metaceutic ApS: Financial statements 2023
CVR: 40638350
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Metaceutic ApS (CVR 40638350) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -1,182,542 and a net result of DKK -2,036,587 compared with DKK -1,801,730 the year before. Equity in the 2023 report amounted to DKK -768,799. The company had 1 employee in the financial year.
- Gross Profit
- DKK -1,182,542
- Profit/Loss
- DKK -2,036,587
- Equity
- DKK -768,799
- Total Assets
- DKK 1,062,532
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -1.2 mio. | -2 mio. | -769 t. | 1 |
| 2022 | - | -987 t. | -1.8 mio. | 1.3 mio. | 2 |
| 2021 | - | -2.2 mio. | -4.2 mio. | 2.1 mio. | 4 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Metaceutic ApS has published its annual report for 2022. Gross profit came to DKK -987,282, and the net result was DKK -1,801,730.
As of June 22, 2023, Jakob Saabye-Brøndum has left the board of directors of Metaceutic ApS.
About Metaceutic ApS
Metaceutic ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali Kazemi Seresht. The company is owned by Ginnerup Capital ApS and A. Kazemi ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,095,622 and a net result of DKK 2,364,576 compared with DKK -1,318,986 the year before. Equity in the 2025 report amounted to DKK 276,791.